Effectiveness of omalizumab in two cases of normocomplementemic urticarial vasculitis due to perivascular mast cell infiltration

Authors :: Harutaka Seshimo
Tatsuo Maeda
Chizu Egusa
Kazutoshi Harada
Namiko Abe
Tomonobu Ito
Yukari Okubo
Source :: Allergology International, Vol 70, Iss 2, Pp 269-270 (2021)
Publication Year :: 2021
Publisher :: Elsevier BV, 2021.

Subjects :: lcsh:Immunologic diseases. Allergy
Pathology
medicine.medical_specialty
Mast cell infiltration
business.industry
medicine
Immunology and Allergy
General Medicine
Omalizumab
lcsh:RC581-607
business
Normocomplementemic urticarial vasculitis
medicine.drug

Tools